Boston Scientific (BSX) Cash from Operations Growth (3y) (2012 - 2026)
Powered by 
Analysis
Boston Scientific (BSX) Cash from Operations Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.43 Bn | 177.83 Bn | 7.27 Bn | 27.41% |
| 2 | Intuitive Surgical | 124.55 Bn | 119.33 Bn | 1.96 Bn | 16.81% |
| 3 | Medtronic | 117.91 Bn | 109.10 Bn | 6.34 Bn | 27.02% |
| 4 | Stryker | 105.51 Bn | 102.03 Bn | 4.50 Bn | 22.38% |
| 5 | Boston Scientific | 66.23 Bn | 65.69 Bn | 3.85 Bn | 30.85% |
| 6 | Edwards Lifesciences | 49.46 Bn | 45.21 Bn | 1.35 Bn | 168.71% |
| 7 | Alcon | 33.87 Bn | 32.41 Bn | 1.68 Bn | 16.21% |
| 8 | Dexcom | 32.08 Bn | 30.13 Bn | 830.00 Mn | 12.26% |
| 9 | Steris | 21.05 Bn | 20.56 Bn | 684.20 Mn | 9.30% |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn | 8.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.85% |
| Mar 31, 2026 | 22.35% |
| Dec 31, 2025 | 19.12% |
| Sep 30, 2025 | 41.90% |
| Jun 30, 2025 | 61.20% |
| Mar 31, 2025 | 124.58% |
| Dec 31, 2024 | 44.96% |
| Sep 30, 2024 | 29.16% |
| Jun 30, 2024 | 8.13% |
| Mar 31, 2024 | -16.73% |
| Dec 31, 2023 | 12.45% |
| Sep 30, 2023 | 2.77% |
| Jun 30, 2023 | 34.74% |
| Mar 31, 2023 | 64.70% |
| Dec 31, 2022 | 5.26% |
| Sep 30, 2022 | -2.17% |
| Jun 30, 2022 | 1.68% |
| Mar 31, 2022 | -29.38% |
| Dec 31, 2021 | 193.02% |
| Sep 30, 2021 | -2.45% |